(+)-catechin multiple interactions ISO RGD:61847 6480464 Catechin inhibits the reaction [Dietary Fats results in increased expression of GPAM mRNA] CTD PMID:23365609 (+)-catechin multiple interactions EXP 6480464 [Catechin co-treated with Dietary Fats] affects the expression of GPAM mRNA CTD PMID:25861419 (+)-dexrazoxane decreases expression EXP 6480464 Dexrazoxane results in decreased expression of GPAM mRNA CTD PMID:26873546 (+)-dexrazoxane multiple interactions EXP 6480464 [Doxorubicin co-treated with Dexrazoxane] results in increased expression of GPAM mRNA CTD PMID:26873546 (+)-schisandrin B multiple interactions ISO RGD:61847 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of GPAM mRNA] CTD PMID:31150632 (-)-epigallocatechin 3-gallate decreases expression ISO RGD:61847 6480464 epigallocatechin gallate results in decreased expression of GPAM mRNA CTD PMID:16988119 (1->4)-beta-D-glucan multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of GPAM mRNA CTD PMID:36331819 1,2-dimethylhydrazine decreases expression EXP 6480464 1, 2-Dimethylhydrazine results in decreased expression of GPAM mRNA CTD PMID:22206623 1-naphthyl isothiocyanate decreases expression ISO RGD:61847 6480464 1-Naphthylisothiocyanate results in decreased expression of GPAM mRNA CTD PMID:25380136 17alpha-ethynylestradiol multiple interactions EXP 6480464 [lard co-treated with Cholesterol co-treated with Sucrose co-treated with Ethinyl Estradiol] results in increased expression of GPAM mRNA, [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GPAM mRNA CTD PMID:17942748 , PMID:24440342 17alpha-ethynylestradiol decreases expression ISO RGD:61847 6480464 Ethinyl Estradiol results in decreased expression of GPAM mRNA CTD PMID:15576828 17beta-estradiol decreases expression ISO RGD:1345985 6480464 Estradiol results in decreased expression of GPAM mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GPAM mRNA more ... CTD PMID:16054899 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of GPAM mRNA CTD PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1345985 6480464 Tetrachlorodibenzodioxin results in increased expression of GPAM mRNA CTD PMID:30096437 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:61847 6480464 Tetrachlorodibenzodioxin results in decreased expression of GPAM mRNA CTD PMID:20959002 , PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:61847 6480464 Tetrachlorodibenzodioxin results in increased expression of GPAM mRNA CTD PMID:22808131 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of GPAM mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1345985 6480464 Tetrachlorodibenzodioxin affects the expression of GPAM mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of GPAM mRNA CTD PMID:18295293 2,4-dinitrotoluene affects expression ISO RGD:61847 6480464 2, 4-dinitrotoluene affects the expression of GPAM mRNA CTD PMID:21346803 2-methylcholine affects expression ISO RGD:1345985 6480464 beta-methylcholine affects the expression of GPAM mRNA CTD PMID:21179406 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:61847 6480464 3 more ... CTD PMID:20959002 , PMID:23196670 3,4-methylenedioxymethamphetamine increases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of GPAM mRNA CTD PMID:20188158 3,4-methylenedioxymethamphetamine increases methylation EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased methylation of GPAM promoter CTD PMID:26251327 3,4-methylenedioxymethamphetamine decreases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of GPAM mRNA CTD PMID:26251327 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of GPAM mRNA more ... CTD PMID:16054899 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1345985 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of GPAM mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane decreases expression ISO RGD:61847 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of GPAM mRNA CTD PMID:25380136 , PMID:30723492 4,4'-sulfonyldiphenol decreases expression EXP 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of GPAM mRNA CTD PMID:33297965 4,4'-sulfonyldiphenol affects methylation EXP 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of GPAM gene CTD PMID:31683443 4-hydroxyphenyl retinamide decreases expression EXP 6480464 Fenretinide results in decreased expression of GPAM mRNA CTD PMID:28973697 6-propyl-2-thiouracil decreases expression ISO RGD:61847 6480464 Propylthiouracil results in decreased expression of GPAM mRNA CTD PMID:24780913 acadesine multiple interactions ISO RGD:1345985 6480464 acadesine inhibits the reaction [[Oleic Acid co-treated with Dibutyl Phthalate] results in increased expression of GPAM protein], acadesine inhibits the reaction [Dibutyl Phthalate results in increased expression of GPAM protein] CTD PMID:33508418 aflatoxin B1 decreases methylation ISO RGD:1345985 6480464 Aflatoxin B1 results in decreased methylation of GPAM gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO RGD:1345985 6480464 Aflatoxin B1 results in decreased expression of GPAM mRNA CTD PMID:22100608 , PMID:27153756 aldrin increases expression EXP 6480464 Aldrin results in increased expression of GPAM mRNA CTD PMID:18579281 all-trans-retinoic acid decreases expression ISO RGD:1345985 6480464 Tretinoin results in decreased expression of GPAM mRNA CTD PMID:33167477 amiodarone increases expression ISO RGD:61847 6480464 Amiodarone results in increased expression of GPAM mRNA CTD PMID:19224547 ammonium chloride affects expression ISO RGD:61847 6480464 Ammonium Chloride affects the expression of GPAM mRNA CTD PMID:16483693 Aroclor 1254 increases expression ISO RGD:61847 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of GPAM mRNA CTD PMID:18178546 atorvastatin calcium multiple interactions ISO RGD:61847 6480464 Atorvastatin inhibits the reaction [Fructose results in increased expression of GPAM mRNA] CTD PMID:19053045 atrazine multiple interactions EXP 6480464 [lard co-treated with Cholesterol co-treated with Sucrose co-treated with Atrazine] results in increased expression of GPAM mRNA CTD PMID:24440342 atrazine decreases expression ISO RGD:1345985 6480464 Atrazine results in decreased expression of GPAM mRNA CTD PMID:22378314 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of GPAM mRNA CTD PMID:19770486 , PMID:22228805 benzo[a]pyrene increases methylation ISO RGD:1345985 6480464 Benzo(a)pyrene results in increased methylation of GPAM promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1345985 6480464 Benzo(a)pyrene results in decreased expression of GPAM mRNA CTD PMID:26238291 , PMID:32234424 benzo[a]pyrene affects expression EXP 6480464 Benzo(a)pyrene affects the expression of GPAM mRNA CTD PMID:22342234 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1345985 6480464 7 more ... CTD PMID:20382639 benzo[a]pyrene diol epoxide I affects expression ISO RGD:1345985 6480464 7 more ... CTD PMID:26238291 benzylpenicillin multiple interactions EXP 6480464 [Penicillin G co-treated with Erythromycin] results in increased expression of GPAM mRNA CTD PMID:27503388 benzylpenicillin increases expression EXP 6480464 Penicillin G results in increased expression of GPAM mRNA CTD PMID:27503388 beta-naphthoflavone multiple interactions ISO RGD:61847 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of GPAM mRNA CTD PMID:18164116 bezafibrate multiple interactions EXP 6480464 PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of GPAM mRNA] CTD PMID:19124612 bezafibrate increases expression EXP 6480464 Bezafibrate results in increased expression of GPAM mRNA, Bezafibrate results in increased expression of GPAM protein CTD PMID:19124612 bezafibrate decreases expression EXP 6480464 Bezafibrate results in decreased expression of GPAM mRNA, Bezafibrate results in decreased expression of GPAM protein CTD PMID:19124612 bisphenol A increases expression ISO RGD:1345985 6480464 bisphenol A results in increased expression of GPAM mRNA CTD PMID:25619500 , PMID:28483554 bisphenol A increases expression ISO RGD:61847 6480464 bisphenol A results in increased expression of GPAM mRNA CTD PMID:30816183 more ... bisphenol A affects expression ISO RGD:1345985 6480464 bisphenol A affects the expression of GPAM mRNA CTD PMID:30903817 bisphenol A multiple interactions ISO RGD:1345985 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of GPAM gene, MIR192 mRNA inhibits the reaction [bisphenol A results in increased expression of GPAM mRNA] CTD PMID:28483554 , PMID:31601247 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of GPAM mRNA CTD PMID:21932408 more ... bisphenol A decreases expression ISO RGD:61847 6480464 bisphenol A results in decreased expression of GPAM mRNA CTD PMID:25181051 Bisphenol B increases expression ISO RGD:1345985 6480464 bisphenol B results in increased expression of GPAM protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:1345985 6480464 bisphenol F results in increased expression of GPAM protein CTD PMID:34186270 buspirone decreases expression ISO RGD:61847 6480464 Buspirone results in decreased expression of GPAM mRNA CTD PMID:24136188 cadmium atom increases expression ISO RGD:61847 6480464 Cadmium results in increased expression of GPAM mRNA CTD PMID:17066326 cadmium dichloride increases expression ISO RGD:61847 6480464 Cadmium Chloride results in increased expression of GPAM mRNA CTD PMID:17066326 , PMID:18329778 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of GPAM mRNA CTD PMID:26352046 caffeine increases phosphorylation ISO RGD:1345985 6480464 Caffeine results in increased phosphorylation of GPAM protein CTD PMID:35688186 carbon nanotube decreases expression EXP 6480464 Nanotubes more ... CTD PMID:25620056 chloroethene increases expression EXP 6480464 Vinyl Chloride results in increased expression of GPAM mRNA CTD PMID:18579281 chlorothalonil multiple interactions EXP 6480464 [procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of GPAM mRNA CTD PMID:33246813 chlorothalonil decreases expression EXP 6480464 tetrachloroisophthalonitrile results in decreased expression of GPAM mRNA CTD PMID:33246813 cholesterol multiple interactions EXP 6480464 [lard co-treated with Cholesterol co-treated with Sucrose co-treated with Atrazine] results in increased expression of GPAM mRNA, [lard co-treated with Cholesterol co-treated with Sucrose co-treated with Ethinyl Estradiol] results in increased expression of GPAM mRNA CTD PMID:24440342 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of GPAM gene CTD PMID:20938992 clofibrate increases expression ISO RGD:61847 6480464 Clofibrate results in increased expression of GPAM mRNA CTD PMID:19224547 copper(II) sulfate affects expression ISO RGD:1345985 6480464 Copper Sulfate affects the expression of GPAM mRNA CTD PMID:19549813 coumarin increases phosphorylation ISO RGD:1345985 6480464 coumarin results in increased phosphorylation of GPAM protein CTD PMID:35688186 crocidolite asbestos decreases expression ISO RGD:1345985 6480464 Asbestos, Crocidolite results in decreased expression of GPAM mRNA CTD PMID:24160326 curcumin decreases expression EXP 6480464 Curcumin results in decreased expression of GPAM mRNA CTD PMID:19297423 curcumin decreases expression ISO RGD:61847 6480464 Curcumin results in decreased expression of GPAM mRNA CTD PMID:27208389 curcumin affects expression EXP 6480464 Curcumin affects the expression of GPAM mRNA CTD PMID:27208389 curcumin multiple interactions EXP 6480464 Curcumin inhibits the reaction [Dietary Fats results in increased expression of GPAM mRNA] CTD PMID:19297423 cyclosporin A decreases expression ISO RGD:1345985 6480464 Cyclosporine results in decreased expression of GPAM mRNA CTD PMID:20106945 more ... cyclosporin A affects expression ISO RGD:1345985 6480464 Cyclosporine affects the expression of GPAM mRNA CTD PMID:25562108 decabromodiphenyl ether decreases expression ISO RGD:61847 6480464 decabromobiphenyl ether results in decreased expression of GPAM mRNA CTD PMID:23640034 dexamethasone multiple interactions EXP 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of GPAM mRNA more ... CTD PMID:16054899 dexamethasone multiple interactions ISO RGD:1345985 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of GPAM mRNA CTD PMID:28628672 dexamethasone increases expression ISO RGD:1345985 6480464 Dexamethasone results in increased expression of GPAM mRNA CTD PMID:25047013 dibutyl phthalate increases expression ISO RGD:1345985 6480464 Dibutyl Phthalate results in increased expression of GPAM protein CTD PMID:33508418 dibutyl phthalate multiple interactions ISO RGD:61847 6480464 Dibutyl Phthalate promotes the reaction [Dietary Fats results in increased expression of GPAM protein] CTD PMID:33508418 dibutyl phthalate multiple interactions ISO RGD:1345985 6480464 [Oleic Acid co-treated with Dibutyl Phthalate] results in increased expression of GPAM protein more ... CTD PMID:33508418 dibutyl phthalate increases expression ISO RGD:61847 6480464 Dibutyl Phthalate results in increased expression of GPAM protein CTD PMID:33508418 dichloroacetic acid increases expression EXP 6480464 Dichloroacetic Acid results in increased expression of GPAM mRNA CTD PMID:28962523 dioxygen multiple interactions EXP 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GPAM mRNA CTD PMID:30529165 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of GPAM mRNA CTD PMID:26873546 doxorubicin multiple interactions EXP 6480464 [Doxorubicin co-treated with Dexrazoxane] results in increased expression of GPAM mRNA CTD PMID:26873546 endosulfan decreases expression ISO RGD:61847 6480464 Endosulfan results in decreased expression of GPAM mRNA CTD PMID:29391264 entacapone decreases expression ISO RGD:1345985 6480464 entacapone results in decreased expression of GPAM protein CTD PMID:29688484 epoxiconazole decreases expression EXP 6480464 epoxiconazole results in decreased expression of GPAM mRNA CTD PMID:35436446 erythromycin A multiple interactions EXP 6480464 [Penicillin G co-treated with Erythromycin] results in increased expression of GPAM mRNA CTD PMID:27503388 erythromycin A increases expression EXP 6480464 Erythromycin results in increased expression of GPAM mRNA CTD PMID:27503388 ethanol multiple interactions EXP 6480464 [Zinc deficiency co-treated with Ethanol] results in decreased expression of GPAM mRNA more ... CTD PMID:18755807 more ... ethanol decreases expression ISO RGD:1345985 6480464 Ethanol results in decreased expression of GPAM mRNA CTD PMID:23378141 ethanol increases expression EXP 6480464 Ethanol results in increased expression of GPAM mRNA CTD PMID:18755807 more ... fenofibrate increases expression ISO RGD:61847 6480464 Fenofibrate results in increased expression of GPAM mRNA CTD PMID:16707586 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of GPAM mRNA CTD PMID:17702527 , PMID:19442681 folic acid multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of GPAM gene CTD PMID:20938992 folic acid multiple interactions ISO RGD:61847 6480464 [Folic Acid affects the susceptibility to Fructose] which affects the expression of GPAM mRNA CTD PMID:31612177 fructose multiple interactions ISO RGD:61847 6480464 [Folic Acid affects the susceptibility to Fructose] which affects the expression of GPAM mRNA, Atorvastatin inhibits the reaction [Fructose results in increased expression of GPAM mRNA] CTD PMID:19053045 , PMID:31612177 fructose increases expression ISO RGD:61847 6480464 Fructose results in increased expression of GPAM mRNA CTD PMID:18346472 , PMID:19053045 fulvestrant multiple interactions ISO RGD:1345985 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of GPAM gene CTD PMID:31601247 fumonisin B1 decreases expression EXP 6480464 fumonisin B1 results in decreased expression of GPAM mRNA CTD PMID:16221962 genistein increases expression EXP 6480464 Genistein results in increased expression of GPAM mRNA CTD PMID:32186404 gentamycin decreases expression ISO RGD:61847 6480464 Gentamicins results in decreased expression of GPAM mRNA CTD PMID:22061828 , PMID:33387578 ginsenoside Re multiple interactions EXP 6480464 ginsenoside Re inhibits the reaction [Dietary Fats results in increased expression of GPAM mRNA] CTD PMID:21971952 glycidol decreases expression ISO RGD:61847 6480464 glycidol results in decreased expression of GPAM mRNA CTD PMID:24915197 GW 6471 multiple interactions ISO RGD:1345985 6480464 GW 6471 inhibits the reaction [[Oleic Acid co-treated with Dibutyl Phthalate] results in increased expression of GPAM protein], GW 6471 inhibits the reaction [Dibutyl Phthalate results in increased expression of GPAM protein] CTD PMID:33508418 hexadecanoic acid increases expression EXP 6480464 Palmitic Acid results in increased expression of GPAM mRNA CTD PMID:29414781 hydrogen peroxide affects expression ISO RGD:1345985 6480464 Hydrogen Peroxide affects the expression of GPAM mRNA CTD PMID:21179406 indometacin multiple interactions ISO RGD:1345985 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of GPAM mRNA CTD PMID:28628672 iron atom increases expression ISO RGD:61847 6480464 Iron deficiency results in increased expression of GPAM mRNA CTD PMID:16629162 iron(0) increases expression ISO RGD:61847 6480464 Iron deficiency results in increased expression of GPAM mRNA CTD PMID:16629162 isoprenaline decreases expression EXP 6480464 Isoproterenol results in decreased expression of GPAM mRNA CTD PMID:21335049 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of GPAM gene CTD PMID:20938992 lipopolysaccharide decreases expression EXP 6480464 Lipopolysaccharides results in decreased expression of GPAM mRNA CTD PMID:16847310 metformin increases expression ISO RGD:61847 6480464 Metformin results in increased expression of GPAM mRNA CTD PMID:31324951 methapyrilene decreases expression ISO RGD:61847 6480464 Methapyrilene results in decreased expression of GPAM mRNA CTD PMID:30467583 methotrexate increases expression ISO RGD:1345985 6480464 Methotrexate results in increased expression of GPAM mRNA CTD PMID:17400583 microcystin-LR increases expression EXP 6480464 cyanoginosin LR results in increased expression of GPAM protein CTD PMID:26984711 Muraglitazar increases expression ISO RGD:61847 6480464 muraglitazar results in increased expression of GPAM mRNA CTD PMID:21515302 N,N-diethyl-m-toluamide multiple interactions ISO RGD:61847 6480464 [Permethrin co-treated with DEET] results in decreased methylation of GPAM gene CTD PMID:33148267 N-nitrosodiethylamine multiple interactions ISO RGD:61847 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of GPAM mRNA CTD PMID:18164116 nickel atom decreases expression ISO RGD:1345985 6480464 Nickel results in decreased expression of GPAM mRNA CTD PMID:24768652 , PMID:25583101 nimesulide decreases expression ISO RGD:61847 6480464 nimesulide results in decreased expression of GPAM mRNA CTD PMID:24136188 O-methyleugenol decreases expression ISO RGD:1345985 6480464 methyleugenol results in decreased expression of GPAM mRNA CTD PMID:32234424 obeticholic acid decreases expression ISO RGD:1345985 6480464 obeticholic acid results in decreased expression of GPAM mRNA CTD PMID:27939613 oleic acid multiple interactions ISO RGD:1345985 6480464 [Oleic Acid co-treated with Dibutyl Phthalate] results in increased expression of GPAM protein more ... CTD PMID:33508418 oxycodone increases expression ISO RGD:61847 6480464 Oxycodone results in increased expression of GPAM mRNA CTD PMID:23439660 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of GPAM mRNA CTD PMID:11264010 paracetamol decreases expression ISO RGD:1345985 6480464 Acetaminophen results in decreased expression of GPAM mRNA CTD PMID:21420995 more ... paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of GPAM mRNA CTD PMID:17562736 perfluorobutanesulfonic acid increases expression ISO RGD:1345985 6480464 perfluorobutanesulfonic acid results in increased expression of GPAM mRNA CTD PMID:35337807 perfluorobutyric acid increases expression ISO RGD:1345985 6480464 perfluorobutyric acid results in increased expression of GPAM mRNA CTD PMID:35337807 perfluorodecanoic acid increases expression ISO RGD:1345985 6480464 perfluorodecanoic acid results in increased expression of GPAM mRNA CTD PMID:35337807 perfluorododecanoic acid increases expression ISO RGD:1345985 6480464 perfluorododecanoic acid results in increased expression of GPAM mRNA CTD PMID:35337807 perfluorohexanoic acid increases expression ISO RGD:1345985 6480464 perfluorohexanoic acid results in increased expression of GPAM mRNA CTD PMID:35337807 perfluorooctane-1-sulfonic acid increases expression ISO RGD:61847 6480464 perfluorooctane sulfonic acid results in increased expression of GPAM mRNA CTD PMID:21723365 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of GPAM mRNA CTD PMID:36331819 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1345985 6480464 perfluorooctane sulfonic acid results in decreased expression of GPAM mRNA CTD PMID:32588087 perfluorooctanesulfonamide increases expression ISO RGD:1345985 6480464 perfluorooctanesulfonamide analog results in increased expression of GPAM mRNA, perfluorooctanesulfonamide results in increased expression of GPAM mRNA CTD PMID:35337807 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of GPAM mRNA CTD PMID:17681415 perfluorooctanoic acid increases expression ISO RGD:61847 6480464 perfluorooctanoic acid results in increased expression of GPAM mRNA CTD PMID:21723365 perfluoropentanoic acid increases expression ISO RGD:1345985 6480464 perfluoropentanoic acid results in increased expression of GPAM mRNA CTD PMID:35337807 perfluoroundecanoic acid increases expression ISO RGD:1345985 6480464 perfluoroundecanoic acid results in increased expression of GPAM mRNA CTD PMID:35337807 permethrin multiple interactions ISO RGD:61847 6480464 [Permethrin co-treated with DEET] results in decreased methylation of GPAM gene CTD PMID:33148267 phenformin increases expression ISO RGD:61847 6480464 Phenformin results in increased expression of GPAM mRNA CTD PMID:31324951 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of GPAM mRNA CTD PMID:19270015 pirinixic acid multiple interactions EXP 6480464 ACAA1B protein inhibits the reaction [pirinixic acid results in increased expression of GPAM mRNA], PPARA protein affects the reaction [pirinixic acid results in increased expression of GPAM mRNA] CTD PMID:15777286 , PMID:19772884 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of GPAM mRNA CTD PMID:11798191 more ... pirinixic acid increases expression ISO RGD:61847 6480464 pirinixic acid results in increased expression of GPAM mRNA CTD PMID:19162173 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of GPAM mRNA CTD PMID:28903501 procymidone multiple interactions EXP 6480464 [procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of GPAM mRNA CTD PMID:33246813 procymidone decreases expression EXP 6480464 procymidone results in decreased expression of GPAM mRNA CTD PMID:33246813 propamocarb decreases expression EXP 6480464 propamocarb results in decreased expression of GPAM mRNA CTD PMID:29137890 quercetin decreases expression ISO RGD:1345985 6480464 Quercetin results in decreased expression of GPAM mRNA CTD PMID:21632981 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [Dietary Fats results in increased expression of GPAM mRNA] CTD PMID:22447684 resveratrol multiple interactions EXP 6480464 resveratrol inhibits the reaction [Ethanol results in increased expression of GPAM mRNA] CTD PMID:18755807 resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of GPAM mRNA CTD PMID:18755807 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of GPAM mRNA CTD PMID:17702527 rotenone affects expression ISO RGD:61847 6480464 Rotenone affects the expression of GPAM mRNA CTD PMID:28374803 serpentine asbestos decreases expression ISO RGD:1345985 6480464 Asbestos, Serpentine results in decreased expression of GPAM mRNA CTD PMID:24160326 sevoflurane affects expression ISO RGD:61847 6480464 sevoflurane affects the expression of GPAM mRNA CTD PMID:15967596 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of GPAM mRNA, sodium arsenite results in decreased expression of GPAM protein CTD PMID:22700541 more ... sodium arsenite decreases expression ISO RGD:1345985 6480464 sodium arsenite results in decreased expression of GPAM mRNA CTD PMID:29301061 steviol multiple interactions EXP 6480464 steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of GPAM mRNA] CTD PMID:25554529 sucrose multiple interactions EXP 6480464 [lard co-treated with Cholesterol co-treated with Sucrose co-treated with Atrazine] results in increased expression of GPAM mRNA, [lard co-treated with Cholesterol co-treated with Sucrose co-treated with Ethinyl Estradiol] results in increased expression of GPAM mRNA CTD PMID:24440342 sulfluramid increases expression ISO RGD:1345985 6480464 sulfluramid results in increased expression of GPAM mRNA CTD PMID:35337807 sunitinib increases expression ISO RGD:1345985 6480464 Sunitinib results in increased expression of GPAM mRNA CTD PMID:31533062 tectoridin multiple interactions EXP 6480464 tectoridin inhibits the reaction [Ethanol results in increased expression of GPAM mRNA] CTD PMID:20637825 Tesaglitazar increases expression ISO RGD:61847 6480464 tesaglitazar results in increased expression of GPAM mRNA CTD PMID:21515302 testosterone increases expression ISO RGD:1345985 6480464 Testosterone results in increased expression of GPAM mRNA CTD PMID:33359661 tetrachloroethene increases expression EXP 6480464 Tetrachloroethylene results in increased expression of GPAM mRNA CTD PMID:28973375 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of GPAM mRNA CTD PMID:17484886 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of GPAM mRNA CTD PMID:31919559 tetrachloromethane multiple interactions ISO RGD:61847 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of GPAM mRNA] CTD PMID:31150632 tetrachloromethane decreases expression ISO RGD:61847 6480464 Carbon Tetrachloride results in decreased expression of GPAM mRNA CTD PMID:31150632 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of GPAM mRNA CTD PMID:23557971 topiramate decreases expression ISO RGD:61847 6480464 topiramate results in decreased expression of GPAM mRNA CTD PMID:16979414 trimellitic anhydride increases expression EXP 6480464 trimellitic anhydride results in increased expression of GPAM mRNA CTD PMID:19042947 troglitazone decreases expression ISO RGD:61847 6480464 troglitazone results in decreased expression of GPAM mRNA CTD PMID:9452481 troglitazone decreases expression ISO RGD:1345985 6480464 troglitazone results in decreased expression of GPAM mRNA CTD PMID:25572481 trovafloxacin decreases expression ISO RGD:61847 6480464 trovafloxacin results in decreased expression of GPAM mRNA CTD PMID:24136188 urethane decreases expression ISO RGD:1345985 6480464 Urethane results in decreased expression of GPAM mRNA CTD PMID:28818685 valdecoxib decreases expression ISO RGD:61847 6480464 valdecoxib results in decreased expression of GPAM mRNA CTD PMID:24136188 valproic acid increases expression ISO RGD:61847 6480464 Valproic Acid results in increased expression of GPAM mRNA CTD PMID:19224547 valproic acid affects methylation ISO RGD:1345985 6480464 Valproic Acid affects the methylation of GPAM gene CTD PMID:29501571 valproic acid affects expression ISO RGD:1345985 6480464 Valproic Acid affects the expression of GPAM mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:1345985 6480464 Valproic Acid results in decreased expression of GPAM mRNA CTD PMID:23179753 , PMID:29501571 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of GPAM mRNA CTD PMID:24489787 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of GPAM mRNA CTD PMID:17292431 vinclozolin increases expression ISO RGD:61847 6480464 vinclozolin results in increased expression of GPAM mRNA CTD PMID:23034163 zinc atom affects expression ISO RGD:61847 6480464 Zinc affects the expression of GPAM mRNA CTD PMID:17181878 zinc atom decreases expression EXP 6480464 Zinc deficiency results in decreased expression of GPAM mRNA CTD PMID:24155903 zinc atom multiple interactions EXP 6480464 [Zinc deficiency co-treated with Ethanol] results in decreased expression of GPAM mRNA CTD PMID:24155903 zinc(0) affects expression ISO RGD:61847 6480464 Zinc affects the expression of GPAM mRNA CTD PMID:17181878 zinc(0) multiple interactions EXP 6480464 [Zinc deficiency co-treated with Ethanol] results in decreased expression of GPAM mRNA CTD PMID:24155903 zinc(0) decreases expression EXP 6480464 Zinc deficiency results in decreased expression of GPAM mRNA CTD PMID:24155903
